Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 1/20 | 0.48 |
| ▸ | P2RY2 | P41231 | 12/20 | 0.48 |
| ▸ | P2RY4 | P51582 | 5/20 | 0.48 |
| ▸ | P2RY14 | Q15391 | 4/20 | 0.48 |
| ▸ | P2RY6 | Q15077 | 7/20 | 0.42 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13715991 | 1.00 | TYMP (0.48) | TYMPP2RY2P2RY4P2RY14P2RY6 | |
| SCHEMBL3918343 | 1.00 | TYMP (0.48) | TYMPP2RY2P2RY4P2RY14P2RY6 | |
| SCHEMBL2108638 | 0.96 | TYMP (0.46) | TYMPP2RY2P2RY4P2RY14P2RY6 | |
| SCHEMBL2108637 | 0.96 | TYMP (0.46) | TYMPP2RY2P2RY4P2RY14P2RY6 | |
| SCHEMBL15841327 | 0.94 | TYMP (0.45) | TYMPP2RY2P2RY4P2RY14P2RY6 | |
| SCHEMBL19971896 | 0.94 | TYMP (0.45) | TYMPP2RY2P2RY4P2RY14P2RY6 | |
| SCHEMBL15841328 | 0.94 | TYMP (0.45) | TYMPP2RY2P2RY4P2RY14P2RY6 | |
| SCHEMBL7553293 | 0.91 | TYMP (0.51) | TYMPP2RY2P2RY4P2RY14P2RY6 | |
| SCHEMBL4451613 | 0.91 | TYMP (0.51) | TYMPP2RY2P2RY4P2RY14P2RY6 | |
| SCHEMBL6831398 | 0.91 | TYMP (0.51) | TYMPP2RY2P2RY4P2RY14P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7569685-B2 | Artificial RNAóS modified at the 2ó-hydroxyl group | JAPAN SCIENCCE AND TECHNOLOGY AGENCY (JP) | 2009-08-04 | — | — | US | disclosed |
| US-20080021206-A1 | Novel Artificial Rnaos Modified At The 2o-Hydroxyl Group | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2008-01-24 | — | — | US | disclosed |
| EP-1726597-A1 | NOVEL ARTIFICIAL RNAóS MODIFIED AT THE 2ó-HYDROXYL GROUP | Japan Science and Technology Agency (JP) | 2006-11-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080021206-A1 | Novel Artificial Rnaos Modified At The 2o-Hydroxyl Group | FBL, NSUN2, METTL16 | TYMP 826/4885P2RY2 1196/4885P2RY4 1747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.